Royal Pharmaceutical

Event Date: 06-Jun-2013
News and Events Image

FOR IMMEDIATE RELEASE:

Royal Pharmaceuticals Re-Introduces the PEDIAPRED® Brand to the healthcare prescription market


Manasquan NJ, June 3, 2013 - Royal Pharmaceuticals announced today they have made available the PEDIAPRED® Brand. 

Healthcare Providers can prescribe PEDIAPRED® by specifying, “Dispense As Written”, “Do Not Substitute”, or “Brand Necessary” on the prescription.

PEDIAPRED® is a brand name
of the generic medicine
prednisolone sodium phosphate, which is a
adrenocortical steroid drug with predominantly glucocorticoid properties

Royal Pharmaceuticals has entered into an exclusive agreement with Granard Pharmaceuticals Sales and Marketing to sell and market Pediapred at the national points of distributions, i.e. wholesalers, chains, mail order, GPO’s, LTC. 

Royal Pharmaceuticals is a specialty pharmaceutical company that markets quality products to healthcare providers and patients. With over 60 years of leadership experience in the pharmaceutical industry, Royal Pharmaceuticals is dedicated to meeting the needs of the healthcare community. Our focus is on improving patient outcomes by responsibly commercializing differentiated branded products.



Contact:
Armand Crupi
Royal Pharmaceuticals
2317 Highway 34
Manasquan, NJ 08759
800 510 3401
acrupi@granardrx.com

Contact Us

 



For more information on our specific products and solutions, contact Royal Pharmaceuticals today.

 


Royal Pharmaceuticals

Atlantic Corporate Center
2317 Highway 34
Manasquan, NJ 08736
Email: msaito@granardrx.com
732-292-2661